Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
An overview of CEPA requirements for organizations operating in Canada. Learn key obligations, compliance responsibilities, and best practices across all sectors.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
ECHA has recommended adding 18 substances of very high concern to the REACH Authorisation List (Annex XIV) to prevent their use as substitutes for other regulated substances. The final decision will be made by the European Commission and other EU bodies.
According to a report by the European Commission, the REACH, CLP and BPR regulations represent almost 1/3 of the regulatory costs that weigh on the chemical industry!
With Brexit looming, only 48% of British companies have transferred their chemical registrations to EU-27 entities, risking the availability of over 700 substances in the EU market. The uncertain political landscape adds to the urgency for companies to prepare for a no-deal scenario.
With the introduction of the harmonized format for reporting to poison control centers, a new requirement for standard information has emerged. These are the UFIs, or Unique Formula Identifier (in English). Affixed to the label, the UFI will make it easy to identify a mixture in the event of a call to poison control centers.
Learn about Current Good Manufacturing Practices (cGMP) regulations, how they ensure high quality products, and the consequences of non-compliance. Understand which parts of the manufacturing process are regulated and when products need to adhere to cGMPs.
The Korean Ministry of Environment has proposed a temporary adjustment to K-REACH regulations to address potential supply chain shortages. This includes simplified registration for new chemical substances and relaxed rules for research and development exemptions until December 2021.
